Geron (GERN) initiates P2 Trial of GRN1005 in Brain Metastases from Breast Cancer
December 12th, 2011
No comments
GERN initiated P2 clinical trial of GRABM-B (GRN1005 against Brain Metastases – Breast cancer) Read more…
Categories: Geron (GERN), initiates P2 Trial of GRN1005
